CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene
BACKGROUND: The antithyroid thioureylenes, propylthiouracil (PTU) and methimazole (MMI), are effective in the treatment of patients with plaque psoriasis. The mechanism of action of the drugs in psoriasis is unknown. Since the drugs reduce circulating IL-12 levels in patients with Graves' hyperthyro...
保存先:
| 出版年: | BMC Dermatol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC169161/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12841851/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-5945-3-3 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|